Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Doses of Alimta in Advanced NSCLC
NCT00078260Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Dec 2003; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00078260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078260.